A cloak of silence surrounds the settled whistleblower lawsuit against ADA for endorsing harmful recipes for those with diabetes; lack of trial means missed opportunity for transparency.
Diabetes epidemic costs billions annually, yet ADA and pharmaceutical industry focus on corporate deals rather than low-carb diet solutions; whistleblower case reveals lack of interests alignment.
#whistleblower-lawsuit #american-diabetes-association #diabetes-epidemic #health-transparency #corporate-influence
[
add
]
[
|
|
...
]